Innovent Biologics

Innovent Biologics,Inc. is a leading biopharmaceutical company in China focused on the discovery, development and manufacturing of complex, high-end biologics for both the Asian and global markets that meet EMA and FDA/cGMP standards. Innovent has an expanding biologics pipeline focused on oncology, inflammatory diseases and ophthalmology. Innovent's strategy is to advance its internal pipeline of proprietary biologic drugs and establish in/out-licensing agreements with global pharmaceutical/biotech companies. Because of its location and emphasis on quality, Innovent is able to leverage China's cost-efficient environment without compromising its world-class quality standards.
Suzhou, CN
101 (est)+10%
Innovent Biologics was founded in 2011 and is headquartered in Suzhou, CN

Innovent Biologics Locations

Suzhou, CN

Innovent Biologics Metrics

Innovent Biologics Summary

Founding Date


Total Funding

$385 M

Latest funding size

$260 M

Time since last funding

about 2 months


We estimate that Innovent Biologics's latest funding round in November 2016 was $260 M. In total, Innovent Biologics has raised $385 M

Innovent Biologics Company Life

You may also be interested in